322 related articles for article (PubMed ID: 37224770)
1. Cross-tissue omics analysis discovers ten adipose genes encoding secreted proteins in obesity-related non-alcoholic fatty liver disease.
Darci-Maher N; Alvarez M; Arasu UT; Selvarajan I; Lee SHT; Pan DZ; Miao Z; Das SS; Kaminska D; Örd T; Benhammou JN; Wabitsch M; Pisegna JR; Männistö V; Pietiläinen KH; Laakso M; Sinsheimer JS; Kaikkonen MU; Pihlajamäki J; Pajukanta P
EBioMedicine; 2023 Jun; 92():104620. PubMed ID: 37224770
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 (
Wu M; Lo TH; Li L; Sun J; Deng C; Chan KY; Li X; Yeh ST; Lee JTH; Lui PPY; Xu A; Wong CM
Elife; 2023 Aug; 12():. PubMed ID: 37580962
[TBL] [Abstract][Full Text] [Related]
3. Circulating anti-Müllerian hormone levels in pre-menopausal women: novel genetic insights from a genome-wide association meta-analysis.
Pujol-Gualdo N; Karjalainen MK; Võsa U; Arffman RK; Mägi R; Ronkainen J; Laisk T; Piltonen TT
Hum Reprod; 2024 May; ():. PubMed ID: 38815977
[TBL] [Abstract][Full Text] [Related]
4. Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE∗3-Leiden.CETP mice.
Ying Z; van Eenige R; Ge X; van Marwijk C; Lambooij JM; Guigas B; Giera M; de Boer JF; Coskun T; Qu H; Wang Y; Boon MR; Rensen PCN; Kooijman S
EBioMedicine; 2023 Jul; 93():104684. PubMed ID: 37379656
[TBL] [Abstract][Full Text] [Related]
5. Identification of autosomal cis expression quantitative trait methylation (cis eQTMs) in children's blood.
Ruiz-Arenas C; Hernandez-Ferrer C; Vives-Usano M; Marí S; Quintela I; Mason D; Cadiou S; Casas M; Andrusaityte S; Gutzkow KB; Vafeiadi M; Wright J; Lepeule J; Grazuleviciene R; Chatzi L; Carracedo Á; Estivill X; Marti E; Escaramís G; Vrijheid M; González JR; Bustamante M
Elife; 2022 Mar; 11():. PubMed ID: 35302492
[TBL] [Abstract][Full Text] [Related]
6. Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease.
Li Z; Zhang B; Liu Q; Tao Z; Ding L; Guo B; Zhang E; Zhang H; Meng Z; Guo S; Chen Y; Peng J; Li J; Wang C; Huang Y; Xu H; Wu Y
EBioMedicine; 2023 Apr; 90():104543. PubMed ID: 37002989
[TBL] [Abstract][Full Text] [Related]
7. Hepatic
Lee YH; Jang HJ; Kim S; Choi SS; Khim KW; Eom HJ; Hyun J; Shin KJ; Chae YC; Kim H; Park J; Park NH; Woo CY; Hong CH; Koh EH; Nam D; Choi JH
Elife; 2021 Dec; 10():. PubMed ID: 34964438
[TBL] [Abstract][Full Text] [Related]
8. BMI in childhood and adolescence is associated with impaired reproductive function-a population-based cohort study from birth to age 50 years.
Laru J; Nedelec R; Koivuaho E; Ojaniemi M; Järvelin MR; Tapanainen JS; Franks S; Tolvanen M; Piltonen TT; Sebert S; Morin-Papunen L
Hum Reprod; 2021 Oct; 36(11):2948-2961. PubMed ID: 34364312
[TBL] [Abstract][Full Text] [Related]
9. Features of the metabolic syndrome in late adolescence are associated with impaired testicular function at 20 years of age.
Hart RJ; Doherty DA; Mori TA; Adams LA; Huang RC; Minaee N; Handelsman DJ; McLachlan R; Norman RJ; Dickinson JE; Olynyk JK; Beilin LJ
Hum Reprod; 2019 Mar; 34(3):389-402. PubMed ID: 30576537
[TBL] [Abstract][Full Text] [Related]
10. Expression of energy metabolism related genes in the gastric tissue of obese individuals with non-alcoholic fatty liver disease.
Mehta R; Birerdinc A; Wang L; Younoszai Z; Moazzez A; Elariny H; Goodman Z; Chandhoke V; Baranova A; Younossi ZM
BMC Gastroenterol; 2014 Apr; 14():72. PubMed ID: 24716593
[TBL] [Abstract][Full Text] [Related]
11. Towards early risk biomarkers: serum metabolic signature in childhood predicts cardio-metabolic risk in adulthood.
Ojanen X; Cheng R; Törmäkangas T; Rappaport N; Wilmanski T; Wu N; Fung E; Nedelec R; Sebert S; Vlachopoulos D; Yan W; Price ND; Cheng S; Wiklund P
EBioMedicine; 2021 Oct; 72():103611. PubMed ID: 34628356
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease development by targeting lipolysis in the white adipose tissue.
Falkevall A; Mehlem A; Folestad E; Ning FC; Osorio-Conles Ó; Radmann R; de Hollanda A; Wright SD; Scotney P; Nash A; Eriksson U
J Hepatol; 2023 May; 78(5):901-913. PubMed ID: 36717026
[TBL] [Abstract][Full Text] [Related]
13. Bavachin protects against diet-induced hepatic steatosis and obesity in mice.
Wei X; Lin L; Yuan QQ; Wang XY; Zhang Q; Zhang XM; Tang KC; Guo MY; Dong TY; Han W; Huang DK; Qi YL; Zhang M; Zhang HB
Acta Pharmacol Sin; 2023 Jul; 44(7):1416-1428. PubMed ID: 36721007
[TBL] [Abstract][Full Text] [Related]
14. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
du Plessis J; van Pelt J; Korf H; Mathieu C; van der Schueren B; Lannoo M; Oyen T; Topal B; Fetter G; Nayler S; van der Merwe T; Windmolders P; Van Gaal L; Verrijken A; Hubens G; Gericke M; Cassiman D; Francque S; Nevens F; van der Merwe S
Gastroenterology; 2015 Sep; 149(3):635-48.e14. PubMed ID: 26028579
[TBL] [Abstract][Full Text] [Related]
15. Increased Secreted Frizzled-Related Protein 5 mRNA Expression in the Adipose Tissue of Women with Nonalcoholic Fatty Liver Disease Associated with Obesity.
Bertran L; Portillo-Carrasquer M; Barrientos-Riosalido A; Aguilar C; Riesco D; Martínez S; Culebradas A; Vives M; Sabench F; Castillo DD; Richart C; Auguet T
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077270
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
[TBL] [Abstract][Full Text] [Related]
17. Association of medically assisted reproduction with offspring cord blood DNA methylation across cohorts.
Caramaschi D; Jungius J; Page CM; Novakovic B; Saffery R; Halliday J; Lewis S; Magnus MC; London SJ; Håberg SE; Relton CL; Lawlor DA; Elliott HR
Hum Reprod; 2021 Jul; 36(8):2403-2413. PubMed ID: 34136910
[TBL] [Abstract][Full Text] [Related]
18. Disease-specific eQTL screening reveals an anti-fibrotic effect of AGXT2 in non-alcoholic fatty liver disease.
Yoo T; Joo SK; Kim HJ; Kim HY; Sim H; Lee J; Kim HH; Jung S; Lee Y; Jamialahmadi O; Romeo S; Jeong WI; Hwang GS; Kang KW; Kim JW; Kim W; Choi M;
J Hepatol; 2021 Sep; 75(3):514-523. PubMed ID: 33892010
[TBL] [Abstract][Full Text] [Related]
19. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.
Orlicky DJ; Libby AE; Bales ES; McMahan RH; Monks J; La Rosa FG; McManaman JL
J Physiol; 2019 Mar; 597(6):1565-1584. PubMed ID: 30536914
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
Milić S; Lulić D; Štimac D
World J Gastroenterol; 2014 Jul; 20(28):9330-7. PubMed ID: 25071327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
